Abstract
Conformational rearrangements are key to the function of riboswitches. These regulatory mRNA regions specifically bind to cellular metabolites using evolutionarily conserved sensing domains and modulate gene expression via adjacent downstream expression platforms, which carry gene expression signals. The regulation is achieved through the ligand-dependent formation of two alternative and mutually exclusive conformations involving the same RNA region. While X-ray crystallography cannot visualize dynamics of such dramatic conformational rearrangements, this method is pivotal to understand RNA–ligand interaction that stabilize the sensing domain and drive folding of the expression platform. X-ray crystallography can reveal local changes in RNA necessary for discriminating cognate and noncognate ligands. This chapter describes preparation of thiamine pyrophosphate riboswitch RNAs and its crystallization with different ligands, resulting in structures with local conformational changes in RNA. These structures can help to derive information on the dynamics of the RNA essential for specific binding to small molecules, with potential for using this information for developing designer riboswitch–ligand systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Serganov A, Nudler E (2013) A decade of riboswitches. Cell 152:17–24
Mandal M, Breaker RR (2004) Gene regulation by riboswitches. Nat Rev Mol Cell Biol 5:451–463
Nudler E, Mironov AS (2004) The riboswitch control of bacterial metabolism. Trends Biochem Sci 29:11–17
Winkler W, Nahvi A, Breaker RR (2002) Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419:952–956
Roth A, Breaker RR (2009) The structural and functional diversity of metabolite-binding riboswitches. Annu Rev Biochem 78:305–334
Richards J, Belasco JG (2021) Widespread protection of RNA cleavage sites by a riboswitch aptamer that folds as a compact obstacle to scanning by RNase E. Mol Cell 81(127–138):e124
Peselis A, Gao A, Serganov A (2015) Cooperativity, allostery and synergism in ligand binding to riboswitches. Biochimie 117:100–109
Panchapakesan SSS, Breaker RR (2021) The case of the missing allosteric ribozymes. Nat Chem Biol 17(4):375–382
Serganov A, Patel DJ (2012) Metabolite recognition principles and molecular mechanisms underlying riboswitch function. Annu Rev Biophys 41:343–370
Baker JL, Sudarsan N, Weinberg Z et al (2012) Widespread genetic switches and toxicity resistance proteins for fluoride. Science 335:233–235
Nahvi A, Sudarsan N, Ebert MS et al (2002) Genetic control by a metabolite binding mRNA. Chem Biol 9:1043
Blount KF, Breaker RR (2006) Riboswitches as antibacterial drug targets. Nat Biotechnol 24:1558–1564
Blount KF, Megyola C, Plummer M et al (2015) Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora. Antimicrob Agents Chemother 59:5736–5746
Blount KF, Wang JX, Lim J et al (2007) Antibacterial lysine analogs that target lysine riboswitches. Nat Chem Biol 3:44–49
Serganov A, Huang L, Patel DJ (2008) Structural insights into amino acid binding and gene control by a lysine riboswitch. Nature 455:1263–1267
Serganov A, Huang L, Patel DJ (2009) Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch. Nature 458:233–237
Mulhbacher J, Brouillette E, Allard M et al (2010) Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog 6:e1000865
Ster C, Allard M, Boulanger S et al (2013) Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog. J Dairy Sci 96:1000–1008
Yan LH, Le Roux A, Boyapelly K et al (2018) Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile. Eur J Med Chem 143:755–768
Pedrolli DB, Matern A, Wang J et al (2012) A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis. Nucleic Acids Res 40:8662–8673
Lee ER, Blount KF, Breaker RR (2009) Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol 6:187–194
Sudarsan N, Cohen-Chalamish S, Nakamura S et al (2005) Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chem Biol 12:1325–1335
Howe JA, Wang H, Fischmann TO et al (2015) Selective small-molecule inhibition of an RNA structural element. Nature 526:672–677
Wang H, Mann PA, Xiao L et al (2017) Dual-targeting small-molecule inhibitors of the Staphylococcus aureus FMN riboswitch disrupt riboflavin homeostasis in an infectious setting. Cell Chem Biol 24:576–588. e576
Warner KD, Hajdin CE, Weeks KM (2018) Principles for targeting RNA with drug-like small molecules. Nat Rev Drug Discov 17:547–558
Connelly CM, Moon MH, Schneekloth JS Jr (2016) The emerging role of RNA as a therapeutic target for small molecules. Cell Chem Biol 23:1077–1090
Mironov AS, Gusarov I, Rafikov R et al (2002) Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 111:747–756
Barrick JE, Breaker RR (2007) The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biol 8:R239
Yadav S, Swati D, Chandrasekharan H (2015) Thiamine pyrophosphate riboswitch in some representative plant species: a bioinformatics study. J Comput Biol 22:1–9
Mukherjee S, Retwitzer MD, Barash D et al (2018) Phylogenomic and comparative analysis of the distribution and regulatory patterns of TPP riboswitches in fungi. Sci Rep 8:5563
Sudarsan N, Barrick JE, Breaker RR (2003) Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 9:644–647
Gong S, Du C, Wang Y (2020) Regulation of the thiamine pyrophosphate (TPP)-sensing riboswitch in NMT1 mRNA from Neurospora crassa. FEBS Lett 594:625–635
Shimizu M, Masuo S, Itoh E et al (2016) Thiamine synthesis regulates the fermentation mechanisms in the fungus Aspergillus nidulans. Biosci Biotechnol Biochem 80:1768–1775
Cheah MT, Wachter A, Sudarsan N et al (2007) Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Nature 447:497–500
Croft MT, Moulin M, Webb ME et al (2007) Thiamine biosynthesis in algae is regulated by riboswitches. Proc Natl Acad Sci USA 104:20770–20775
Bocobza S, Adato A, Mandel T et al (2007) Riboswitch-dependent gene regulation and its evolution in the plant kingdom. Genes Dev 21:2874–2879
Wachter A, Tunc-Ozdemir M, Grove BC et al (2007) Riboswitch control of gene expression in plants by splicing and alternative 3′ end processing of mRNAs. Plant Cell 19:3437–3450
Li S, Breaker RR (2013) Eukaryotic TPP riboswitch regulation of alternative splicing involving long-distance base pairing. Nucleic Acids Res 41:3022–3031
Kubodera T, Watanabe M, Yoshiuchi K et al (2003) Thiamine-regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5′-UTR. FEBS Lett 555:516–520
Chauvier A, Picard-Jean F, Berger-Dancause JC et al (2017) Transcriptional pausing at the translation start site operates as a critical checkpoint for riboswitch regulation. Nat Commun 8:13892
Rodionov DA, Vitreschak AG, Mironov AA et al (2002) Comparative genomics of thiamin biosynthesis in procaryotes. New genes and regulatory mechanisms. J Biol Chem 277:48949–48959
Kulshina N, Edwards TE, Ferre-D’amare AR (2010) Thermodynamic analysis of ligand binding and ligand binding-induced tertiary structure formation by the thiamine pyrophosphate riboswitch. RNA 16:186–196
Rentmeister A, Mayer G, Kuhn N et al (2007) Conformational changes in the expression domain of the Escherichia coli thiM riboswitch. Nucleic Acids Res 35:3713–3722
Serganov A, Polonskaia A, Phan AT et al (2006) Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch. Nature 441:1167–1171
Edwards TE, Ferre-D’amare AR (2006) Crystal structures of the thi-box riboswitch bound to thiamine pyrophosphate analogs reveal adaptive RNA-small molecule recognition. Structure 14:1459–1468
Thore S, Leibundgut M, Ban N (2006) Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand. Science 312:1208–1211
Meredith J., Zeller Ashok, Nuthanakanti Kelin, Li Jeffrey, Aubé Alexander, Serganov Kevin M., Weeks (2022) Subsite Ligand Recognition and Cooperativity in the TPP Riboswitch: Implications for Fragment-Linking in RNA Ligand Discovery. ACS Chemical Biology 17(2) 438–448
Thore S, Frick C, Ban N (2008) Structural basis of thiamine pyrophosphate analogues binding to the eukaryotic riboswitch. J Am Chem Soc 130:8116–8117
Warner KD, Ferre-D’amare AR (2014) Crystallographic analysis of TPP riboswitch binding by small-molecule ligands discovered through fragment-based drug discovery approaches. Methods Enzymol 549:221–233
Warner KD, Homan P, Weeks KM et al (2014) Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically. Chem Biol 21:591–595
Antunes D, Jorge NN, Garcia De Souza Costa M et al (2019) Unraveling RNA dynamical behavior of TPP riboswitches: a comparison between Escherichia coli and Arabidopsis thaliana. Sci Rep 9:4197
Milligan JF, Groebe DR, Witherell GW et al (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 15:8783–8798
Pikovskaya O, Serganov AA, Polonskaia A et al (2009) Preparation and crystallization of riboswitch-ligand complexes. Methods Mol Biol 540:115–128
Rong M, Durbin RK, Mcallister WT (1998) Template strand switching by T7 RNA polymerase. J Biol Chem 273:10253–10260
Helm M, Brule H, Giege R et al (1999) More mistakes by T7 RNA polymerase at the 5′ ends of in vitro-transcribed RNAs. RNA 5:618–621
Pleiss JA, Derrick ML, Uhlenbeck OC (1998) T7 RNA polymerase produces 5′ end heterogeneity during in vitro transcription from certain templates. RNA 4:1313–1317
Ferre-D’amare AR, Doudna JA (1996) Use of cis- and trans-ribozymes to remove 5′ and 3′ heterogeneities from milligrams of in vitro transcribed RNA. Nucleic Acids Res 24:977–978
Guo HC, Collins RA (1995) Efficient trans-cleavage of a stem-loop RNA substrate by a ribozyme derived from neurospora VS RNA. EMBO J 14:368–376
Martick M, Scott WG (2006) Tertiary contacts distant from the active site prime a ribozyme for catalysis. Cell 126:309–320
Price SR, Ito N, Oubridge C et al (1995) Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies. J Mol Biol 249:398–408
Walker SC, Avis JM, Conn GL (2003) General plasmids for producing RNA in vitro transcripts with homogeneous ends. Nucleic Acids Res 31:e82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply
About this protocol
Cite this protocol
Nuthanakanti, A., Ariza-Mateos, A., Serganov, A. (2023). X-Ray Crystallography to Study Conformational Changes in a TPP Riboswitch. In: Ding, J., Stagno, J.R., Wang, YX. (eds) RNA Structure and Dynamics. Methods in Molecular Biology, vol 2568. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2687-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2687-0_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2686-3
Online ISBN: 978-1-0716-2687-0
eBook Packages: Springer Protocols